Category Archives: Cell Biology

Cloud Computing in Cell Biology, Genomics and Drug Development Market Size And Forecast (2020-2026)| With Post Impact Of Covid-19 By Top Leading…

This report studies the Cloud Computing in Cell Biology, Genomics and Drug Development Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Cloud Computing in Cell Biology, Genomics and Drug Development Market analysis segmented by companies, region, type and applications in the report.

The report offers valuable insight into the Cloud Computing in Cell Biology, Genomics and Drug Development market progress and approaches related to the Cloud Computing in Cell Biology, Genomics and Drug Development market with an analysis of each region. The report goes on to talk about the dominant aspects of the market and examine each segment.

#Key Players: Google Inc.,Amazon Web Services, Inc.,IBM Corp.,Oracle Corporation,Microsoft Corp.,Arisglobal,Benchling,Box Inc,Cisco Systems,Dell Emc,Cognizant,Dincloud,Exponential-e,Informatica.

Get a Free Sample [emailprotected] https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-cloud-computing-in-cell-biology-genomics-and-drug-development-market-report-history-and-forecast-2015-2026-breakdown-data-by-companies-key-regions-types-and-application?utm_source=khabarsouthasia&utm_medium=14

The global Cloud Computing in Cell Biology, Genomics and Drug Development market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cloud Computing in Cell Biology, Genomics and Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2020-2026.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Cloud Computing in Cell Biology, Genomics and Drug Development market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Cloud Computing in Cell Biology, Genomics and Drug Development market by identifying its various sub segments.

Focuses on the key global Cloud Computing in Cell Biology, Genomics and Drug Development players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Cloud Computing in Cell Biology, Genomics and Drug Development with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Cloud Computing in Cell Biology, Genomics and Drug Development submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

Table of Contents: Cloud Computing in Cell Biology, Genomics and Drug Development Market

Key questions answered in this report

Get complete Report @ https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-cloud-computing-in-cell-biology-genomics-and-drug-development-market-report-history-and-forecast-2015-2026-breakdown-data-by-companies-key-regions-types-and-application?utm_source=khabarsouthasia&utm_medium=14

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Continue reading here:
Cloud Computing in Cell Biology, Genomics and Drug Development Market Size And Forecast (2020-2026)| With Post Impact Of Covid-19 By Top Leading...

Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 – Times of San Diego

Share This Article:A stem cell research center at UC Davis. Courtesy California Institute for Regenerative MedicineBy Barbara Feder Ostrov | CalMatters

Californias stem cell research agency was supposed to be winding down its operations right about now, after a 16-year run and hundreds of millions in grants to scientists researching cutting-edge treatments for diabetes, cancer, Alzheimers and other diseases.

Support Times of San Diego's growthwith a small monthly contribution

Instead, the taxpayer-supported California Institute for Regenerative Medicine will get a $5.5 billion reboot after voters earlier this month narrowly passed the Proposition 14bond measure. The overall cost of the bonds with interest will total about $7.8 billion.

Were thrilled that California voters saw fit to continue the work weve done, said Jonathan Thomas, chair of the agencys governing board. California has always had a frontier mentality and a love for the cutting edge, and the work that CIRM has done has put it on the very forefront of regenerative medicine.

Even with Californias economy in a coronavirus-induced tailspin and somescientists arguingthat stem cell research no longer needs taxpayer support,Prop. 14passed with 51 percent of the vote after well-financed supporters pourednearly $21 millioninto the Yes on 14 campaign. The measure was essentially a rerun of Proposition 71, which California voters approved in 2004 after a since-revoked federal ban on embryonic stem cell research.

The cash infusion is expected to keep the institute running for another 10 to 15 years, although the agency will see some significant changes under Prop. 14.

The institute also must contend with longstanding concerns over conflicts of interest that have dogged it since its inception, observers say. About 80% of the money distributed has gone to universities and companies tied to agency board members, according to an analysisby longtime agency watchdog David Jensen, a former Sacramento Bee journalist who runs theCalifornia Stem Cell Reportblog and wrote abookon the institute.

Prop. 14 allows the agency to fund a wider array of research projects even some that dont involve stem cells, but instead are related to genetics, personalized medicine and aging.

Thats necessary because the field has evolved, said Paul Knoepfler, a UC Davis professor of cell biology who studies the role of stem cells in cancer and writes a stem cell blog. He received a 2009 grant from the institute.

Stem cells are interesting and important, but there are going to be a lot of new therapies in the next 10 years that are not stem-cell centric, Knoepfler said.

Other changes for the agency include:

Ysabel Duron, who joined the institutes board late last year, said she sees her role as promoting equity in opportunities for both researchers and patients and ensuring that treatments resulting from the research can benefit all Californians.

Researchers in particular need to boost the diversity of patients in their clinical trials and do a better job communicating the value of their work to the public, Duron said, noting that nearly 40% of Californians are Latino.

We need to keep researchers feet to the fire, said Duron, a former television journalist and founder of the Latino Cancer Institute. They need to show us a plan and we need to reward them.

To date, the agency has funded 64 clinical trials of treatments for many types of cancer, sickle cell disease, spinal cord injuries, diabetes, kidney disease and amyotrophic lateral sclerosis, commonlyknown as Lou Gehrigs disease.But the most advanced trials involve therapies for relatively rare conditions, such asSevere Combined Immunodeficiency known as the bubble baby disease, Jensen noted. That therapy is being reviewed by the FDA but has not yet been approved.

Cancer, heart disease these are the big killers. Thats what most people are interested in, Jensen said. You can fund something for a rare disease, but that doesnt affect the majority of Californians.

And, Jensen asks, what will happen after the agency runs out of money again? Will taxpayers once again be asked to refill its coffers? There was hope when the agency began that revenues from successful treatments would sustain its grant-making in the years to come, but the institute has only received a few hundred thousand dollars, not nearly enough to become self-sustaining without taxpayer support, according to theLegislative Analysts Office.

The sustainability issue is important and its hard to address, Jensen said. The money doesnt last forever.

CalMatters is a public interest journalism venture committed to explaining how Californias state Capitol works and why it matters.

Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 was last modified: November 28th, 2020 by Editor

>> Subscribe to Times of San Diegos free daily email newsletter! Click here

Follow this link:
Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 - Times of San Diego

Inflammation produced by bacterial infection ‘alerts’ the brain stem cells – News-Medical.net

The study, directed by Isabel Farias and published in the November digital edition of the journal Cell Stem Cell, reveals that the inflammation produced by a bacterial infection 'alerts' the brain stem cells and prepares their activation for the production of new neurons. The study represents a new advance in the field of regenerative medicine.

The team of researchers from the Molecular Neurobiology group of the University of Valencia, led by the professor of Cell Biology Isabel Farias, has just published in the journal Cell Stem Cell the results of a work that sheds light on the role of inflammation in the normal programming of adult brain stem cell activation to produce new neurons throughout life.

Our tissues are constantly renewed thanks to stem cells, which generate new specialized cells to replace those that are lost through "wear and tear". These stem cells are located in very specific locations within tissues, which are known as microenvironments or niches, and in which stem cells interact with other types of cells.

The new findings indicate that brain stem cells also respond to changes that occur outside the brain. This study, carried out in mice, has verified that the inflammation produced by a bacterial infection in any part of the body is capable of temporarily activating brain stem cells and preparing them for action. When the inflammation subsides, these cells return to their quiescent state.

The work allows us to better understand the relationships between stem cells and the systemic environment, that is, the rest of the organism, as knowledge on the subject is very limited. We are used to stem cells responding to their closest microenvironment, but evidence is beginning to emerge showing that they can respond to what is happening in any part of the body thanks to molecules that are distributed through the circulatory system."

Isabel Farias, Professor of Cell Biology, University of Valencia

The work of the research team contributes, once again, new data to the study and advancement of regenerative medicine, a field of science that seeks therapeutic solutions based on stem cells for degenerative processes, such as Alzheimer's or Parkinson's diseases in which neuroinflammation is usually detected.

"We have always been more concerned about chronic inflammation that is associated with many diseases and is very negative for our organs, but it is a defence mechanism against damage or infection", explains Jos Manuel Morante, co-director of the work. "For this reason, it is important to find out the role of inflammation in the regulation of stem cells", he concludes.

Several doctors from the University of Valencia (Germn Belenguer, Ana Domingo, Toni Jordn, Sacri R. Ferrn and Jos Manuel Morante) and researchers in training Pere Duart and Laura Blasco have participated in the research. Farias' team belongs to the Molecular Neurobiology group of the Institute of Biotechnology and Biomedicine of the same University, the Centre for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) and the RETIC of Cell Therapy of the Carlos III Health Institute, and is a Prometheus group of excellence of the Valencian Government.

Source:

Journal reference:

Belenguer, G., et al. (2020) Adult Neural Stem Cells Are Alerted by Systemic Inflammation through TNF- Receptor Signaling. Cell Stem Cell. doi.org/10.1016/j.stem.2020.10.016.

Go here to see the original:
Inflammation produced by bacterial infection 'alerts' the brain stem cells - News-Medical.net

Researcher Examining CBD Effects on Metabolic Syndrome | Newsroom – UC Merced University News

About 35 percent of Americans have metabolic syndrome, a group of risk factors that raises the risk of cardiovascular disease the leading cause of death in the United States.

If you have three of these five issues, you have metabolic syndrome, according to the American Heart Association:

Department of Molecular and Cell Biology Chair and Health Sciences Research Institute memberProfessor Rudy Ortiz is launching a new project to find out if cannabidiol (CBD), either derived from hemp or synthesized in the lab, can have positive effects on issues within metabolic syndrome.

Ortiz will receive $300,000 over the next two years from the Center for Medical Cannabis Research (CMCR) at UC San Diego to see whether CBD can ameliorate hypertension and glucose intolerance in models of metabolic syndrome.

There have been two different studies showing two different results, so we dont know what the truth is, Ortiz said. No study has looked at this directly in a controlled setting, so our data is applicable no matter what it shows.

Professor Anna Song, director of the Nicotine and Cannabis Policy Center at UC Merced, agreed.

Professor Ortizs study will be an important contribution. Our communities are barraged with messages regarding the benefits of CBD and cannabis, but the science isnt just there yet, Song said. This study will be extremely helpful in shedding some light on where CBD is helpful and where it might not help at all.

This pilot study is one important step on the path to human trials if the results are positive.

We need to keep our minds open about what plant-based compounds of any kind can offer, Ortiz said. There has been so much stigma around cannabis, but its becoming more accepted, especially its medicinal benefits.

Heart disease and Type 2 diabetes are primary outcomes of metabolic syndrome, and high blood pressure can lead to stroke, heart attack, vision loss and kidney disease.

Professor Ortizs work exemplifies UC Merceds leadership in using science to explore creative solutions to medical problems that affect millions of Americans, School of Natural Sciences Dean Betsy Dumont said. The potential of this work to identify effective, low-cost treatments that could be made widely available is exciting.

Go here to read the rest:
Researcher Examining CBD Effects on Metabolic Syndrome | Newsroom - UC Merced University News

MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution – Newswise

Newswise MURFREESBORO, Tenn. A first-of-its-kind study led by Middle Tennessee State University biology researcher Elizabeth Barnes suggests that a difference in culture and beliefs between science instructors and students may inadvertently lead to low acceptance of evolution among minority students particularly Black students in biology.

Barnes and Arizona State University researchers asked whether Black and Hispanic students tended to reject evolution more than students from other racial/ethnic identities and whether any differences could be explained by the fact they tend to be more religious.

The study, published Friday, Nov. 20, by CBE Life Sciences Educations quarterly journal, can be found here.

Christianity is popular among 65% of college biology students, but not among the biologists (25%) who are teaching students, which helped the research group understand the motivation for the study.

Further, when looking at students from minority populations, the gap between biologists and student religious affiliation is even wider Black students tend to have stronger religious cultures and backgrounds compared to majority populations.

Researchers found that rejection of evolution was particularly high for Black students, but once they controlled for religious background in their statistical models, the differences between Black and white students were diminished.

This is a concerning finding for STEM (science, technology, engineering and math) educators because Black students are already minoritized in biology and they are particularly absent in fields that emphasize evolution such as ecology and evolutionary biology, said Barnes, who joined the MTSU faculty in August. Our study starts to offer some explanation for why.

Researchers suggest that a solution is to use instructional techniques that highlight the compatibility between religion and evolution rather than where they might conflict.

Science instructors who are often secular themselves are hesitant to address religion and when they do it is often in a way that highlights conflict between religion and science and not compatibility, Barnes said.

To promote an equitable and comfortable STEM environment for religious students, science instructors should more often highlight views such as theistic evolution, for which student can both believe in God and recognize evolution as credible science, she added.

Barnes was joined in the research by K. Supriya, Hayley M. Dunlop, Taija M. Hendrix, Gale M. Sinatra and Sara E. Brownell. They began collecting data five years ago.

We collected a lot of data and spent a lot of time revising the work based on feedback and reading about the experiences of Black and Hispanic individuals, Barnes said.

Barnes labs website can be found here.

CBE Life Sciences Education is a free, online quarterly journal published by the American Society of Cell Biology. It publishes peer-reviewed articles on life science education at the K-12, undergraduate and graduate levels.

About Liz Barnes

Assistant professor Elizabeth Barnesis an MTSU science education researcher. She studies the intersections of science and religion, how individuals perceive the relationship between science and religion and how science educators can foster productive conversations with communities and students of faith to promote science education.

Coming from Arizona State University, where she earned bachelors, masters and doctoral degrees, and was a National Science Foundation Graduate Research Fellow, Barnes arrived with grants to continue her research at MTSU.

I came to MTSU to study how to effectively teach controversial topics in biology to students across different religious and political spectrums, she said. I was lured to MTSU because of the Mathematics and Science Education Ph.D. program, which will allow me to mentor graduate students and build a robust research program.

On deck: My past and current research focus is on perceptions of evolution and I have studied how to make evolution education more inclusive for students from different religious and racial/ethnic backgrounds, she said. I am now excited to be embarking on projects exploring perceptions of climate change, vaccines and COVID19.

Originally posted here:
MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution - Newswise

Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes – India Education Diary

Ottawa: There are more than 300,000 Canadians living with type 1 diabetes (T1D), an autoimmune disease with no known cause or cure, resulting in the dysfunction, damage or loss of pancreatic beta cells that produce insulin in our bodies. People with T1D must treat themselves with insulin several times per day to keep their blood glucose levels normal, and despite their best efforts, they often experience serious, and even life-threatening, complications.

To mark the end of Diabetes Awareness Month, Sonia Sidhu, Member of Parliament for Brampton South, on behalf of the Honourable Patty Hajdu, Minister of Health, announced an investment of $6 million through the CIHR-JDRF Partnership to Defeat Diabetes for two Canadian research teams to accelerate the development of stem cell-based therapies for the treatment of T1D.

Stem cells show great promise as a source of insulin-producing cells that could be transplanted to provide a new source of insulin, to replace dysfunctional, damaged or lost pancreatic beta cells. Canada has a remarkable legacy in leading discoveries in this area. Stem cells were discovered in Toronto in 1961, and in 2000, a team in Edmonton were the first to pioneer transplantation of pancreatic islets (the part of the pancreas that contains insulin-producing cells). These achievements represent important steps toward a treatment that will allow people with T1D to live healthy lives without daily insulin injections.

The research teams are led by Dr. Maria Cristina Nostro at the University Health Network and the University of Toronto and Dr. Francis Lynn at the BC Childrens Hospital Research Institute and the University of British Columbia. The teams will build on Canadas demonstrated research excellence and leadership in clinical islet transplantation, stem cell biology, diabetes, immunology and genetic engineering to accelerate stem cell-based therapies for T1D. They will work in collaboration with other Canadian researchers to tackle some of the biggest scientific challenges that impede our progress in this area and move us closer to a future where people with T1D will no longer rely on insulin therapy.

This funding was provided by the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD), and JDRF Canada, through the CIHR-JDRF Partnership to Defeat Diabetes established in 2017. Each partner will invest $3 million over five years. This investment is part of a large research initiative, 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes, funded by CIHR and partners. This initiative commemorates the 100th anniversary of the discovery of insulin to be marked in 2021a discovery that changed the lives of millions of Canadians and people around the world and won researchers Sir Frederick Banting and John Macleod the Nobel Prize in Physiology or Medicine.

More here:
Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - India Education Diary

Biology Textbooks Wrong? New Research Reveals the Secret Behind a Key Cellular Process – SciTechDaily

For the first time, researchers describe how Rho protein really stops gene expression.

New research has identified and described a cellular process that, despite what textbooks say, has remained elusive to scientists until now precisely how the copying of genetic material that, once started, is properly turned off.

The finding concerns a key process essential to life: the transcription phase of gene expression, which enables cells to live and do their jobs.

During transcription, an enzyme called RNA polymerase wraps itself around the double helix of DNA, using one strand to match nucleotides to make a copy of genetic material resulting in a newly synthesized strand of RNA that breaks off when transcription is complete. That RNA enables production of proteins, which are essential to all life and perform most of the work inside cells.

Just as with any coherent message, RNA needs to start and stop in the right place to make sense. A bacterial protein called Rho was discovered more than 50 years ago because of its ability to stop, or terminate, transcription. In every textbook, Rho is used as a model terminator that, using its very strong motor force, binds to the RNA and pulls it out of RNA polymerase. But a closer look by these scientists showed that Rho wouldnt be able to find the RNAs it needs to release using the textbook mechanism.

We started studying Rho, and realized it cannot possibly work in ways people tell us it works, said Irina Artsimovitch, co-lead author of the study and professor of microbiology at The Ohio State University.

The research, published online by the journalScience today, November 26, 2020, determined that instead of attaching to a specific piece of RNA near the end of transcription and helping it unwind from DNA, Rho actually hitchhikes on RNA polymerase for the duration of transcription. Rho cooperates with other proteins to eventually coax the enzyme through a series of structural changes that end with an inactive state enabling release of the RNA.

The team used sophisticated microscopes to reveal how Rho acts on a complete transcription complex composed of RNA polymerase and two accessory proteins that travel with it throughout transcription.

This is the first structure of a termination complex in any system, and was supposed to be impossible to obtain because it falls apart too quickly, Artsimovitch said.

It answers a fundamental question transcription is fundamental to life, but if it were not controlled, nothing would work. RNA polymerase by itself has to be completely neutral. It has to be able to make any RNA, including those that are damaged or could harm the cell. While traveling with RNA polymerase, Rho can tell if the synthesized RNA is worth making and if not, Rho releases it.

Artsimovitch has made many important discoveries about how RNA polymerase so successfully completes transcription. She didnt set out to counter years of understanding about Rhos role in termination until an undergraduate student in her lab identified surprising mutations in Rho while working on a genetics project.

Rho is known to silence the expression of virulence genes in bacteria, essentially keeping them dormant until theyre needed to cause infection. But these genes do not have any RNA sequences that Rho is known to preferentially bind. Because of that, Artsimovitch said, it has never made sense that Rho looks only for specific RNA sequences, without even knowing if they are still attached to RNA polymerase.

In fact, the scientific understanding of the Rho mechanism was established using simplified biochemical experiments that frequently left out RNA polymerase in essence, defining how a process ends without factoring in the process itself.

In this work, the researchers used cryo-electron microscopy to capture images of RNA polymerase operating on a DNA template in Escherichia coli, their model system. This high-resolution visualization, combined with high-end computation, made accurate modeling of transcription termination possible.

RNA polymerase moves along, matching hundreds of thousands of nucleotides in bacteria. The complex is extremely stable because it has to be if the RNA is released, it is lost, Artsimovitch said. Yet Rho is able to make the complex fall apart in a matter of minutes, if not seconds. You can look at it, but you cant get a stable complex to analyze.

Using a clever method to trap complexes just before they fall apart enabled the scientists to visualize seven complexes that represent sequential steps in the termination pathway, starting from Rhos engagement with RNA polymerase and ending with a completely inactive RNA polymerase. The team created models based on what they saw, and then made sure that these models were correct using genetic and biochemical methods.

Though the study was conducted in bacteria, Artsimovitch said this termination process is likely to occur in other forms of life.

It appears to be common, she said. In general, cells use similar working mechanisms from a common ancestor. They all learned the same tricks as long as these tricks were useful.

Reference: 26 November 2020, Science.

Artsimovitch, working with an international research team of collaborators, co-led the study with Markus Wahl, a former Ohio State graduate student now at Freie Universitt Berlin.

This work was supported by grants from the German Research Foundation; the German Federal Ministry of Education and Research; the Indian Council of Medical Research; the Department of Biotechnology, Government of India; the National Institutes of Health; and the Sigrid Juslius Foundation.

More here:
Biology Textbooks Wrong? New Research Reveals the Secret Behind a Key Cellular Process - SciTechDaily

MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution – Wgnsradio

MTSU science education researcher and biology assistant professor Elizabeth Barnes and five colleagues have published in CBE Life Sciences Educations quarterly journal. The study suggests that a difference in culture and beliefs between science instructors and students may inadvertently lead to low acceptance of evolution among minority students particularly Black students in biology. (MTSU photo by J. Intintoli)

MURFREESBORO, Tenn. A first-of-its-kind study led byMiddle Tennessee State University biologyresearcherElizabeth Barnessuggests that a difference in culture and beliefs between science instructors and students may inadvertently lead to low acceptance of evolution among minority students particularly Black students in biology.

Barnes and Arizona State University researchers asked whether Black and Hispanic students tended to reject evolution more than students from other racial/ethnic identities and whether any differences could be explained by the fact they tend to be more religious.

The study, published Friday, Nov. 20, byCBE Life Sciences Educationsquarterly journal, can be foundhere.

Christianity is popular among 65% of college biology students, but not among the biologists (25%) who are teaching students, which helped the research group understand the motivation for the study.

Further, when looking at students from minority populations, the gap between biologists and student religious affiliation is even wider Black students tend to have stronger religious cultures and backgrounds compared to majority populations.

Researchers found that rejection of evolution was particularly high for Black students, but once they controlled for religious background in their statistical models, the differences between Black and white students were diminished.

This is a concerning finding for STEM (science, technology, engineering and math) educators because Black students are already minoritized in biology and they are particularly absent in fields that emphasize evolution such as ecology and evolutionary biology, said Barnes, who joined the MTSU faculty in August. Our study starts to offer some explanation for why.

Researchers suggest that a solution is to use instructional techniques that highlight the compatibility between religion and evolution rather than where they might conflict.

Science instructors who are often secular themselves are hesitant to address religion and when they do it is often in a way that highlights conflict between religion and science and not compatibility, Barnes said.

To promote an equitable and comfortable STEM environment for religious students, science instructors should more often highlight views such as theistic evolution, for which student can both believe in God and recognize evolution as credible science, she added

Barnes was joined in the research byK. Supriya,Hayley M. Dunlop,Taija M. Hendrix,Gale M. SinatraandSara E. Brownell. They began collecting data five years ago.

We collected a lot of data and spent a lot of time revising the work based on feedback and reading about the experiences of Black and Hispanic individuals, Barnes said.

Barnes labs website can be foundhere.

CBE Life Sciences Education is a free, online quarterly journal published by the American Society of Cell Biology. It publishes peer-reviewed articles on life science education at the K-12, undergraduate and graduate levels.

About Liz Barnes

Assistant professor ElizabethBarnesis an MTSU science education researcher. She studies the intersections of science and religion, how individuals perceive the relationship between science and religion and how science educators can foster productive conversations with communities and students of faith to promote science education.

Coming from Arizona State University, where she earned bachelors, masters and doctoral degrees, and was a National Science Foundation Graduate Research Fellow, Barnes arrived with grants to continue her research at MTSU.

I came to MTSU to study how to effectively teach controversial topics in biology to students across different religious and political spectrums, she said. I was lured to MTSU because of theMathematics and Science Education Ph.D. program, which will allow me to mentor graduate students and build a robust research program.

On deck: My past and current research focus is on perceptions of evolution and I have studied how to make evolution education more inclusive for students from different religious and racial/ethnic backgrounds, she said. I am now excited to be embarking on projects exploring perceptions of climate change, vaccines and COVID19.

Go here to read the rest:
MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution - Wgnsradio

More Evidence that Cellular Death by Iron Could Be Promising Avenue of Cancer Treatment – On Cancer – Memorial Sloan Kettering

Summary

Genetic mutations that give cancers a metabolic boost may also leave them vulnerable to drugs that promote a particular form of cell death, Sloan Kettering Institute researchers have found.

If there is a silver lining in cancers chaotic biology, its that the same traits that give cancer cells a growth advantage often present opportunities for sabotaging them.

Thats the central idea behind a new research paper published November 23in Proceedings of the National Academy of Sciences (PNAS) by Xuejun Jiang, a cell biologist in the Sloan Kettering Institute, and Craig Thompson, President and CEO of Memorial Sloan Kettering. They found that cancer cells often exhibit metabolic changes that make them vulnerable to a particular type of cell death called ferroptosis.

Cell Biology Program

MSK researchers explore the molecular mechanisms that control normal cell behavior and how these mechanisms are disrupted in cancer.

Ferroptosis literally, death by iron is often triggered by oxidative stress, the buildup in cells of free radicals and other corrosive chemicals that are byproducts of using oxygen to burnfuel for energy. But many cancer cells, which need abundant amounts of energy to grow and divide, have found a way around this problem.

Genetic mutations that allow cancer cells to cope with oxidative stress make them more resistant to ferroptosis, Dr. Jiang says. Another way to say this is that without the benefit of those mutations, cancer cells might be very, very sensitive to ferroptosis.

He and his colleagues, including postdoctoral fellows Junmei Yi and Jiajun Zhu, tested this idea by giving mice a combination of drugs one that promotes ferroptosis and one that blocks the effect of the mutations. The results of this one-two punch were dramatic.

The particular mutations Dr. Jiang and colleagues studied affect a signal-sending pathway called PI3K-AKT-mTOR, which controls metabolism. Mutations in this pathway are among the most common found in cancer. That likely reflects the fact that cancer cells have increased metabolic demands owing to how quickly they reproduce. Cancers with mutations in the PI3K-AKT-mTOR pathway are some of the most difficult to treat.

The team found that tumor cells with these mutations demonstrated a hardy resistance to an experimental ferroptosis-inducing drugthat wasadministered to cells growing in a dish. When the scientists added drugs that block the action of this metabolic pathway to the ferroptosis-inducing drug, the cancer cells died.

Next, they tested whether this same effect would be seen in mouse models of breast and prostate cancers containing these mutations. Indeed, the drug combination resulted in near-complete tumor destruction in the mice.

These were some of the most significant tumor regressions I've ever seen coming from experiments in my lab.

These were some of the most significant tumor regressions Ive ever seen coming from experiments in my lab, Dr. Jiang says.

He and his collaborators further showed that the way the mutated PI3K-AKT-mTOR pathwayprotects cancer cells is by increasing the activity of a protein that is involved in making lipids for the cells outer membrane. These extra lipids help to protect the cells against oxidative stress, and therefore ferroptosis. Blocking PI3K-AKT-mTOR prevents this lipid synthesis and re-sensitizes the cells to ferroptosis.

The new findings complement previous work from the Jiang lab, published in 2019 in the journal Nature. In that paper, Dr. Jiang found the some cancers have mutations that make them more sensitive to ferroptosis, even without administering metabolism-altering drugs. In a sense, the new results represent the flipside of the equation.

The key point is that many cancers have genetic alterations that can be exploited to trigger ferroptosis and kill the cells. Its an exciting way to think about developing new cancer treatments.

The team has applied for a patent related to this work. Their next step is to test the drug combination in tumor samples obtained from patients being treated at MSK.

Visit link:
More Evidence that Cellular Death by Iron Could Be Promising Avenue of Cancer Treatment - On Cancer - Memorial Sloan Kettering

Symphony of Cellular Activities Revealed by Fluorescent Imaging Technique – SciTechDaily

MIT researchers have developed a way to simultaneously image up to five different molecules within a cell, by targeting glowing reporters to distinct locations inside the cell. This approach could allow scientists to learn much more about the complex signaling networks that control most cell functions. Credit: Courtesy of the researchers

Fluorescent imaging technique simultaneously captures different signal types from multiple locations in a live cell.

Within a single cell, thousands of molecules, such as proteins, ions, and other signaling molecules, work together to perform all kinds of functions absorbing nutrients, storing memories, and differentiating into specific tissues, among many others.

Deciphering these molecules, and all of their interactions, is a monumental task. Over the past 20 years, scientists have developed fluorescent reporters they can use to read out the dynamics of individual molecules within cells. However, typically only one or two such signals can be observed at a time, because a microscope cannot distinguish between many fluorescent colors.

MIT researchers have now developed a way to image up to five different molecule types at a time, by measuring each signal from random, distinct locations throughout a cell. This approach could allow scientists to learn much more about the complex signaling networks that control most cell functions, says Edward Boyden, the Y. Eva Tan Professor in Neurotechnology and a professor of biological engineering, media arts and sciences, and brain and cognitive sciences at MIT.

There are thousands of molecules encoded by the genome, and theyre interacting in ways that we dont understand. Only by watching them at the same time can we understand their relationships, says Boyden, who is also a member of MITs McGovern Institute for Brain Research and Koch Institute for Integrative Cancer Research.

In a new study, Boyden and his colleagues used this technique to identify two populations of neurons that respond to calcium signals in different ways, which may influence how they encode long-term memories, the researchers say.

Boyden is the senior author of the study, which was published on November 23, 2020, in Cell. The papers lead authors are MIT postdoc Changyang Linghu and graduate student Shannon Johnson.

Just like listening to the sound of a single instrument from an orchestra is far from enough to fully appreciate a symphony, Linghu says, by enabling observations of multiple cellular signals at the same time, our technology will help us understand the symphony of cellular activities. These four images compare various ways scientists make molecular activity visible, with the new technique on the bottom right. Credit: Courtesy of the researchers. Edited by MIT News

To make molecular activity visible within a cell, scientists typically create reporters by fusing a protein that senses a target molecule to a protein that glows. This is similar to how a smoke detector will sense smoke and then flash a light, says Johnson, who is also a fellow in the Yang-Tan Center for Molecular Therapeutics. The most commonly used glowing protein is green fluorescent protein (GFP), which is based on a molecule originally found in a fluorescent jellyfish.

Typically a biologist can see one or two colors at the same time on a microscope, and many of the reporters out there are green, because theyre based on the green fluorescent protein, Boyden says. What has been lacking until now is the ability to see more than a couple of these signals at once.

Just like listening to the sound of a single instrument from an orchestra is far from enough to fully appreciate a symphony, Linghu says, by enabling observations of multiple cellular signals at the same time, our technology will help us understand the symphony of cellular activities.

To boost the number of signals they could see, the researchers set out to identify signals by location instead of by color. They modified existing reporters to cause them to accumulate in clusters at different locations within a cell. They did this by adding two small peptides to each reporter, which helped the reporters form distinct clusters within cells.

Its like having reporter X be tethered to a LEGO brick, and reporter Z tethered to a KNEX piece only LEGO bricks will snap to other LEGO bricks, causing only reporter X to be clustered with more of reporter X, Johnson says.

With this technique, each cell ends up with hundreds of clusters of fluorescent reporters. After measuring the activity of each cluster under a microscope, based on the changing fluorescence, the researchers can identify which molecule was being measured in each cluster by preserving the cell and staining for peptide tags that are unique to each reporter. The peptide tags are invisible in the live cell, but they can be stained and seen after the live imaging is done. This allows the researchers to distinguish signals for different molecules even though they may all be fluorescing the same color in the live cell.

Using this approach, the researchers showed that they could see five different molecular signals in a single cell. To demonstrate the potential usefulness of this strategy, they measured the activities of three molecules in parallel calcium, cyclic AMP, and protein kinase A (PKA). These molecules form a signaling network that is involved with many different cellular functions throughout the body. In neurons, it plays an important role in translating a short-term input (from upstream neurons) into long-term changes such as strengthening the connections between neurons a process that is necessary for learning and forming new memories.

Applying this imaging technique to pyramidal neurons in the hippocampus, the researchers identified two novel subpopulations with different calcium signaling dynamics. One population showed slow calcium responses. In the other population, neurons had faster calcium responses. The latter population had larger PKA responses. The researchers believe this heightened response may help sustain long-lasting changes in the neurons.

The researchers now plan to try this approach in living animals so they can study how signaling network activities relate to behavior, and also to expand it to other types of cells, such as immune cells. This technique could also be useful for comparing signaling network patterns between cells from healthy and diseased tissue.

In this paper, the researchers showed they could record five different molecular signals at once, and by modifying their existing strategy, they believe they could get up to 16. With additional work, that number could reach into the hundreds, they say.

That really might help crack open some of these tough questions about how the parts of a cell work together, Boyden says. One might imagine an era when we can watch everything going on in a living cell, or at least the part involved with learning, or with disease, or with the treatment of a disease.

Read Real Time Spying on the Symphony of Cellular Signals That Drive Biology for more on this research.

Reference: Spatial multiplexing of fluorescent reporters for dynamic imaging of signal transduction networks by Changyang Linghu, Shannon L. Johnson, Pablo A. Valdes, Or A. Shemesh, Won Min Park, Demian Park, Kiryl D. Piatkevich, Asmamaw T. Wassie, Yixi Liu, Bobae An, Stephanie A. Barnes, Orhan T. Celiker, Chun-Chen Yao, Chih-Chieh (Jay) Yu, Ru Wang, Katarzyna P. Adamala, Mark F. Bear, Amy E. Keating and Edward S. Boyden, 23 November 2020, Cell.DOI:: 10.1016/j.cell.2020.10.035

The research was funded by the Friends of the McGovern Institute Fellowship; the J. Douglas Tan Fellowship; Lisa Yang; the Yang-Tan Center for Molecular Therapeutics; John Doerr; the Open Philanthropy Project; the HHMI-Simons Faculty Scholars Program; the Human Frontier Science Program; the U.S. Army Research Laboratory; the MIT Media Lab; the Picower Institute Innovation Fund; the National Institutes of Health, including an NIH Directors Pioneer Award; and the National Science Foundation.

Read this article:
Symphony of Cellular Activities Revealed by Fluorescent Imaging Technique - SciTechDaily